To evaluate the diagnostic efficacy of serum tRF-17-WS7K092 in GC, we first performed ROC analysis of serum tRF-17-WS7K092 and traditional tumor markers (CEA, CA199, and CA724) in 136 GC patients and 136 healthy donors. This evidence concerns the gene CEACAM5 and neoplasm.